JANE STREET GROUP, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 245 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$14,377,316
+484.1%
173,786
+502.6%
0.00%
+200.0%
Q1 2024$2,461,324
-70.1%
28,838
-70.0%
0.00%
-50.0%
Q4 2023$8,229,910
+278.5%
96,245
+296.5%
0.00%
+100.0%
Q3 2023$2,174,285
+55.6%
24,272
+47.9%
0.00%
Q2 2023$1,397,488
+69.3%
16,414
+64.6%
0.00%
Q1 2023$825,265
-40.6%
9,973
-43.5%
0.00%
-100.0%
Q4 2022$1,389,352
-36.3%
17,665
-40.0%
0.00%0.0%
Q3 2022$2,181,000
+173.3%
29,458
+140.6%
0.00%
Q2 2022$798,000
-29.3%
12,242
-31.4%
0.00%
Q1 2022$1,128,000
-69.2%
17,848
-74.2%
0.00%
-100.0%
Q4 2021$3,668,000
+21.1%
69,161
+61.2%
0.00%0.0%
Q3 2021$3,028,000
-10.9%
42,900
-15.8%
0.00%0.0%
Q2 2021$3,398,000
-64.7%
50,977
-41.3%
0.00%
-75.0%
Q1 2021$9,639,000
+3933.1%
86,825
+4219.7%
0.00%
Q4 2020$239,000
-96.0%
2,010
-97.1%
0.00%
-100.0%
Q3 2020$5,961,000
-80.4%
68,316
-79.9%
0.00%
-87.0%
Q2 2020$30,383,000
+5869.2%
339,239
+6538.7%
0.02%
Q1 2020$509,000
+46.3%
5,110
+68.7%
0.00%
Q4 2019$348,000
-50.6%
3,029
-45.8%
0.00%
-100.0%
Q3 2019$705,000
-29.2%
5,591
-50.9%
0.00%
-50.0%
Q1 2019$996,000
-87.9%
11,383
-87.6%
0.00%
-89.5%
Q2 2018$8,257,000
+1806.9%
92,075
+738.8%
0.02%
+850.0%
Q2 2017$433,00010,9770.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders